Clozapin-Mepha 25 mg
Clozapin-Mepha 25 mg is a medicine authorised by Swissmedic under authorisation number 66937. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 02 May 2018 and the authorisation is limited until 01 June 2027. ATC code N05AH02 places the medicine in the group Psycholeptics.
| Authorisation number | 66937 |
|---|---|
| Name | Clozapin-Mepha 25 mg |
| Full name | Clozapin-Mepha 25 mg, Tabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | N05AH02 |
| First authorisation | 02 May 2018 |
| Authorisation validity | 01 June 2027 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Clozapin-Mepha 25 mg, Tabletten | A | 02 May 2018 |
| 2 | Clozapin-Mepha 100 mg, Tabletten | A | 02 May 2018 |
| 3 | Clozapin-Mepha 200 mg, Tabletten | A | 02 May 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 50 | Tablette(n) | N05AH02 | 01.05.0. | A |
| 2 | 50 | Tablette(n) | N05AH02 | 01.05.0. | A |
| 3 | 50 | Tablette(n) | N05AH02 | 01.05.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Clozapin-Mepha 25 mg authorised in Switzerland?
Yes. Clozapin-Mepha 25 mg is authorised by Swissmedic under authorisation number 66937, data as of 01 September 2026. The authorisation is limited until 01 June 2027.
Which dispensing category does Clozapin-Mepha 25 mg have?
Clozapin-Mepha 25 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Clozapin-Mepha 25 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.